• Kristine BreuerEmail author
  • Thomas Werfel
Reference work entry


Phototherapy is an effective strategy in the treatment of inflammatory skin diseases such as atopic dermatitis and has been used for decades in the treatment of palmoplantar dermatoses. There is a wide variety of phototherapeutic regimens including broadband UVB (BB-UVB, 280–320 nm wavelength), narrowband UVB (NB-UVB, 311–312 nm), broadband UVA (320–400 nm), UVA1 (340–400 nm), and photochemotherapy (psoralen plus UVA, PUVA). UVB radiation is incapable of penetrating deeply into the skin. Therefore, it mainly affects the epidermis. In contrast, UVA radiation reaches also the dermis. This chapter gives an overview of the role of phototherapy in the management of occupational skin diseases.


Phototherapy UV radiation UV irradiation UVB NB-UVB BB-UVB UVA UVA1 PUVA Local PUVA Cream PUVA Bath PUVA Systemic PUVA Oral PUVA psoralen 8-MOP Blue LED light Treatment Therapy UV regimens EDEN survey UV-free phototherapy Skin cancer Squamous cell carcinoma Therapy guidelines Treatment guidelines 


  1. An L, Dong G-Q, Gao Q et al (2010) Effects of UVA on TNF-a, IL-1b, and IL-10 expression levels in human keratinocytes and intervention studies with an antioxidant and a JNK inhibitor. Photodermatol Photoimmunol Photomed 26:28–35PubMedCrossRefGoogle Scholar
  2. Aragane Y, Kulms D, Luger TA, Schwarz T (1997) Downregulation of IFN-g-activated STAT-1 by ultraviolet light. Proc Natl Acad Sci USA 94:11490–11495PubMedCrossRefGoogle Scholar
  3. Becker D, Langer E, Seemann M et al (2011) Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis. PLoS One 6:e20566PubMedPubMedCentralCrossRefGoogle Scholar
  4. Beissert S, Mohammad T, Torri H et al (1997) Regulation of tumor antigen presentation by urocanic acid. J Immunol 159:92–96PubMedGoogle Scholar
  5. Breuckmann F, von Kobyletzki G, Avermaete A et al (2002) Mononuclear cells in atopic dermatitis in vivo; immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Eur J Med Res 7:315–322PubMedGoogle Scholar
  6. Diepgen TL, Elsner P, Schliemann S et al (2009) Management of hand eczema. Guideline of the German Society of Dermatology (Deutsche Dermatologische Gesellschaft, DDG).
  7. Engin B, Oguz O (2005) Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. Int J Dermatol 44:337–339PubMedCrossRefGoogle Scholar
  8. Epstein JH (1968) UVL-induced stimulation of DNA synthesis in hairless mouse epidermis. J Invest Dermatol 52:445CrossRefGoogle Scholar
  9. Falcone D, Uzunbajakava NE, van Abeleen F et al (2018) Effects of blue light on inflammation and skin barrier recovery following acute perturbation. Pilot study results in healthy human subjects. Photodermatol Photoimmunol Photomed 34:184–193PubMedCrossRefGoogle Scholar
  10. Fischer MR, Abel M, Lopez Kostka S, Rudolph B, Becker D, von Stebut E (2013) Blue light irradiation suppresses dendritic cells activation in vitro. Exp Dermatol 22:558–560PubMedCrossRefGoogle Scholar
  11. Gambichler T, Rotterdam S, Tigges C, Altmeyer P, Bechera FG (2008) Impact of ultraviolet radiation on the expression of marker proteins of gap and adhesion junctions in human epidermis. Photodermatol Photoimmunol Photomed 24:318–321PubMedCrossRefGoogle Scholar
  12. Garza ZCF, Born M, Hilbers PAJ, van Riel NAW, Liebmann J (2017) Visible light therapy: molecular mechanisms and therapeutic opportunities. Curr Med Chem. Epub ahead of printCrossRefGoogle Scholar
  13. Grattan CE, Carmichael AJ, Shuttleworth GJ, Foulds IS (1991) Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol 71:118–122PubMedPubMedCentralGoogle Scholar
  14. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M (1999) Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 15:87–89PubMedCrossRefGoogle Scholar
  15. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E et al (1999) Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 141:497–501PubMedCrossRefGoogle Scholar
  16. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS (2008) Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 159:931–935PubMedCrossRefGoogle Scholar
  17. Keemss K, Pfaff S, Born M, Liebmann J, Merk HF, von Felbert V (2016) Prospective randomized study on the efficacy and safety of local UV-free blue light treatment of eczema. Dermatology 232:496–502PubMedCrossRefGoogle Scholar
  18. Kleinpenning MM, Smits T, Frunt MH, van Erp PE, van der Kerkhof PC, Gerritsen RM (2010) Clinical and histological effects of blue light on normal skin. Photodermatol Photoimmunol Photomed 2010:16–21CrossRefGoogle Scholar
  19. Kleinpenning MM, Otero ME, van Erp PE, Gerritsen MJ, van de Kerkhof PC (2012) Efficacy of blue light vs. red light in the treatment of psoriasis: a double blind, randomized comparative study. J Eur Acad Dermatol Venereol 26:219–225PubMedCrossRefGoogle Scholar
  20. Kock A, Schwarz T, Kirnbauer R et al (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614PubMedCrossRefGoogle Scholar
  21. Krutmann J, Medve-Koenigs K, Ruzicka T, Ranft U, Wilkens JH (2005) Ultraviolet-free phototherapy. Photodermatol Photoimmunol Photomed 21:59–61PubMedCrossRefGoogle Scholar
  22. Kulms D, Pöppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T (1999) Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to ultraviolet B radiation. Proc Natl Acad Sci USA 96:7974–7979PubMedCrossRefGoogle Scholar
  23. Lee JH, An HT, Chung JH, Kim KH, Eun HC, Cho KH (2002) Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes. Photodermatol Photoimmunol Photomed 18:253–261PubMedCrossRefGoogle Scholar
  24. Lee E, Koo J, Berger T (2005) UVB and skin cancer risk: a review of the literature. Int J Dermatol 44:355–360PubMedCrossRefGoogle Scholar
  25. Liebmann J, Born M, Kolb-Bachofen V (2010) Blue-light irradiation regulates proliferation and differentiation in human skin cells. J Invest Dermatol 130:259PubMedCrossRefGoogle Scholar
  26. Lim JL, Stern RS (2005) High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 124:505–513PubMedCrossRefGoogle Scholar
  27. Maari C, Viau G, Bissonnette R (2003) Repeated exposure to blue light does not improve psoriasis. J Am Acad Dermatol 49:55–58PubMedCrossRefGoogle Scholar
  28. Marcil I, Stern RS (2001) Squamous-cell cancer of the skin in patients given PUVA and cyclosporine: nested cohort crossover study. Lancet 358:1042–1045PubMedCrossRefGoogle Scholar
  29. Morison WL, Parrish JA, Fitzpatrick TB (1978) Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles. Br J Dermatol 99:293–302PubMedCrossRefGoogle Scholar
  30. Morita A, Werfel T, Stege H et al (1997) Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 186:1763–1768PubMedPubMedCentralCrossRefGoogle Scholar
  31. Mork NJ, Austad J (1983) Short-wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands. Acta Derm Venereol 63:87–89PubMedGoogle Scholar
  32. Nijsten TEC, Stern RS (2003a) The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A. A cohort study. J Invest Dermatol 121:252–258PubMedCrossRefGoogle Scholar
  33. Nijsten TEC, Stern RS (2003b) Oral retinoid use reduced cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 49:644–650PubMedCrossRefGoogle Scholar
  34. Nordal EJ, Christensen OB (2004) Treatment of chronic hand dermatoses with UVB-TL01. Acta Derm Venereol 84:302–304PubMedCrossRefGoogle Scholar
  35. O’Kane D, McLoone NM, Jenkinson H, Alderdice D, Badri M (2008) Efficacy of topical PUVA soaks for palmoplantar dermatoses: an audit. Photodermatol Photoimmunol Photomed 24:279–284PubMedCrossRefGoogle Scholar
  36. Ozawa M, Ferenczi K, Kikuchi T et al (1999) 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189:711–718PubMedPubMedCentralCrossRefGoogle Scholar
  37. Pearse AD, Gaskell SA, Marks R (1987) Epidermal changes in human skin following irradation with either UVB of UVA. J Invest Dermatol 88:83–87PubMedCrossRefGoogle Scholar
  38. Petering H, Breuer K, Herbst R, Kapp A, Werfel T (2003) Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 50:68–72CrossRefGoogle Scholar
  39. Pfaff S, Liebmann J, Born M, Merk HF, von Felbert V (2015) Prospective randomized long-term study on the efficacy and safety of UV-free blue light for treating mild psoriasis vulgaris. Dermatology 231:24–34PubMedCrossRefGoogle Scholar
  40. Pieternel CM, Pasker-de-Jong M, Wielink G (1999) Treatment with UV-B for psoriasis and nonmelanoma skin cancer. A systematic review of the literature. Arch Dermatol 135:834–840Google Scholar
  41. Polderman MC, Govaert JC, le Cessie S, Pavel S (2003) A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 28:584–587PubMedPubMedCentralCrossRefGoogle Scholar
  42. Raap U, Kenneweg C, Kapp A, Werfel T (2008) New and rarely used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors. Hautarzt 59:710–716PubMedCrossRefGoogle Scholar
  43. Rivas JM, Ullrich SE (1992) Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 149: 3865–3871PubMedGoogle Scholar
  44. Rosén K, Mobacken H, Swanbeck G (1987) Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol 67:48–54PubMedGoogle Scholar
  45. Schempp CM, Müller H, Czech W, Schöpf E, Simon JC (1997) Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 36:733–737PubMedPubMedCentralCrossRefGoogle Scholar
  46. Schiener R, Gottlöber P, Müller B et al (2005) PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study. Photodermatol Photoimmunol Photomed 21:62–67PubMedPubMedCentralCrossRefGoogle Scholar
  47. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J (1998) UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 78:318–319PubMedCrossRefGoogle Scholar
  48. Schwarz A, Maeda A, Kernebeck K et al (2004) Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172:1036–1043PubMedCrossRefGoogle Scholar
  49. Sezer E, Etikan I (2007) Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed 23:10–14PubMedPubMedCentralCrossRefGoogle Scholar
  50. Shephard SE, Schregenberger N, Dummer R, Pnizzon RG (1998) Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotions (Meladinine) in local PUVA therapy. Dermatology 197:25–30PubMedCrossRefGoogle Scholar
  51. Shintani Y, Yasuda Y, Kobayashi K, Maeda A, Morita A (2008) Narrowband ultraviolet B radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed 24:32–37PubMedCrossRefGoogle Scholar
  52. Shroff A, Malajian D, Czarnwicki T et al (2016) Use of the 308nm excimer laser for the treatment of chronic and and foot eczema. Int J Dermatol 55:e447–e453PubMedCrossRefGoogle Scholar
  53. Simons JR, Bohnen IJWE, Van der Valk PGM (1997) A left-right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks’ treatment. Clin Exp Dermatol 22:7–10CrossRefGoogle Scholar
  54. Sjövall P, Christensen OB (1987) Local and systemic effects of UVB irradiation in patients with chronic hand eczema. Acta Derm Venereol 67:538–541PubMedGoogle Scholar
  55. Stern RS, Lange R (1988) Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91:120–124PubMedCrossRefGoogle Scholar
  56. Stern RS, Nichols KT, Väkeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 336:1041–1045PubMedCrossRefGoogle Scholar
  57. Tuchinda C, Lim HW, Strickland FM, Guzmán EA, Wong HK (2007) Comparison of broadband UVB, narrowband UVB, broadband UVA and UVA1 on activation of apoptotic pathways in human peripheral blood mononuclear cells. Photodermatol Photoimmunol Photomed 23:2–9PubMedCrossRefGoogle Scholar
  58. Tzaneva S, Kittler H, Thallinger C, Hönigsmann H, Tanew A (2009) Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed 25:101–105PubMedCrossRefGoogle Scholar
  59. Van Coevorden AM, Coenraads PJ, Svensson A et al (2004) Overview of studies of treatments for hand eczema. Br J Dermatol 151:446–451PubMedCrossRefGoogle Scholar
  60. Weinstabl A, Hoff-Lesch S, Merk HF, von Felbert V (2011) Prospective randomized study on the efficacy of blue light in the treatment of psoriasis vulgaris. Dermatology 223:251–259PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Private PracticeReinbekGermany
  2. 2.Department of Dermatology and AllergyKlinik für Dermatologie und Venerologie, Hannover Medical SchoolHannoverGermany

Personalised recommendations